SHIFT: Studying HIV Immunology After Fecal Transplant
Status:
Withdrawn
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
SHIFT is a randomized, longitudinal, prospective, blinded, three-arm study to determine the
safety and tolerability of Fecal Microbiota Transplant (FMT) in HIV-infected participants on
stable antiretroviral therapy (ART).